Ana Maria Muñoz-Marmol (Ana Muñoz, Ana Maria Muñoz Mármol, Ana M Muñoz-Marmol)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 7

Top Topics

Early Breast Cancer

Ejection Fraction

Epidermal Growth Factor Receptor

Endoplasmic Reticulum

Top Venues

Exploration of targeted anti-tumor therapy

Clinical cancer research : an official journal of the American Association for Cancer Research

Virchows Archiv : an international journal of pathology

This page only lists publications with an associated author ORCID identifier.

Publications

Laura Pons, Laura Hernández, Aintzane Urbizu, Paula Osorio, Paula Rodríguez-Martínez, Eva Castella, Ana Maria Muñoz-Marmol, Carolina Sanz, Laura Arnaldo, Eudald Felip, Vanesa Quiroga, Gustavo Tapia, Mireia Margelí, Pedro Luis Fernandez
Pre- and Post-Neoadjuvant Clinicopathological Parameters Can Help in the Prognosis and the Prediction of Response in HER2+ and Triple Negative Breast Cancer. Cancers 15 (12) (2023)
Sviatoslav Chekhun, Assumpció Lopez-Paradís, Aintzane Urbizu, Teresa Morán, Anabel Mañes, Marc Cucurull, Carlos Martínez-Barenys, Iris Teruel, Gloria Moragas, Enric Carcereny, Ana Maria Muñoz-Marmol, Maria Saigí
Is oligoprogression a potentially curable disease in epidermal growth factor receptor mutant lung adenocarcinoma? Exploration of targeted anti-tumor therapy 4 (6) (2023)
Laura Pons, Laura Hernández, Aintzane Urbizu, Paula Osorio, Paula Rodríguez-Martínez, Eva Castella, Ana Maria Muñoz-Marmol, Carolina Sanz, Laura Arnaldo, Eudald Felip, Vanesa Quiroga, Gustavo Tapia, Mireia Margelí, Pedro Luis Fernandez
Pre- and Post-Neoadjuvant Clinicopathological Parameters Can Help in the Prognosis and the Prediction of Response in HER2+ and Triple Negative Breast Cancer. Cancers 15 (12) (2023)
Natalia Papaleo, Fina Climent, Gustavo Tapia, Luis Luizaga, Juan Azcarate, Jan Bosch-Schips, Ana Maria Muñoz-Marmol, Marta Salido, Carmen Lome-Maldonado, Ivonne Vazquez, Lluís Colomo
Round-robin testing for LMO2 and MYC as immunohistochemical markers to screen MYC rearrangements in aggressive large B-cell lymphoma. Virchows Archiv : an international journal of pathology (2023)
Sviatoslav Chekhun, Assumpció Lopez-Paradís, Aintzane Urbizu, Teresa Morán, Anabel Mañes, Marc Cucurull, Carlos Martínez-Barenys, Iris Teruel, Gloria Moragas, Enric Carcereny, Ana Maria Muñoz-Marmol, Maria Saigí
Is oligoprogression a potentially curable disease in epidermal growth factor receptor mutant lung adenocarcinoma? Exploration of targeted anti-tumor therapy 4 (6) (2023)
Cristina Carrato, Francesc Alameda, Anna Esteve-Codina, Estela Pineda Losada, Oriol Arpí, Maria Martinez-García, Mar Mallo, Marta Gut, Raquel Lopez-Martos, Sonia Del Barco, Teresa Ribalta, Jaume Capellades, Josep Puig, Oscar Gallego, Carlos Mesia, Ana Maria Muñoz-Marmol, Ivan Archilla, Montserrat Arumí, Julie Marie Blanc, Beatriz Bellosillo, Silvia Menendez, Anna Esteve, Silvia Bagué, Ainhoa Hernandez, Jordi Craven-Bartle, Rafael Fuentes, Noemí Vidal, Iban Aldecoa, Nuria de la Iglesia, Carmen Balana
Glioblastoma TCGA Mesenchymal and IGS 23 Tumors are Identifiable by IHC and have an Immune-phenotype Indicating a Potential Benefit from Immunotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (24) (2020)
Anna Esteve-Codina, Francesc Alameda, Cristina Carrato, Estela Pineda Losada, Oriol Arpí, Maria Martinez-García, Mar Mallo, Marta Gut, Marc Dabad, Avelina Tortosa, Sonia Del Barco, Jaume Capellades, Josep Puig, Oscar Gallego, Teresa Pujol, Laura Oleaga, Juan Miguel Gil-Gil, Cristian de Quintana-Schmidt, Izaskun Valduvieco, Anna Martinez-Cardus, Beatriz Bellosillo, Ana Maria Muñoz-Marmol, Anna Esteve, Marta Domenech, Angels Camins, Jordi Craven-Bartle, Salvador Villa, Jordi Marruecos, Nuria de la Iglesia, Carmen Balana
RNA sequencing and Immunohistochemistry Reveal ZFN7 as a Stronger Marker of Survival than Molecular Subtypes in G-CIMP-negative Glioblastoma. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (2) (2020)